NCT02215213

Brief Summary

The study is randomized blinded trial of Vitamin D supplementation to pregnant women; the study participants will receive Vitamin D in supplement form. Pregnant women will be individually randomized to three groups receiving a dose of 400, 2000 and 4000 IU/ day till the time of delivery.A blood sample will also be collected from the participant at the time of recruitment /before the starting of the supplementation for the assessment of Calcium, Phosphorus, Alkaline Phosphatase and Vitamin D levels. The second blood sample for vitamin D level to assess vitamin D status will be done after completion of the supplementation phase at the time of delivery (till 48 hours of delivery). The samples will be sent to Aga Khan University laboratory

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
350

participants targeted

Target at P75+ for not_applicable pregnancy

Timeline
Completed

Started Jun 2013

Typical duration for not_applicable pregnancy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2013

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

August 6, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 13, 2014

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2016

Completed
Last Updated

July 18, 2016

Status Verified

July 1, 2016

Enrollment Period

2.1 years

First QC Date

August 6, 2014

Last Update Submit

July 15, 2016

Conditions

Keywords

Vitamin DpregnancyPakistan

Outcome Measures

Primary Outcomes (1)

  • pregnancy out come

    Hypovitaminosis, Pre eclampsia, Preterm labour, preterm birth, low birth weight, Still birth rates.

    At delivery of neonate

Secondary Outcomes (1)

  • Prevalence of vitamin D deficiency in pregnant women

    at recruitment into study (first trimester)

Study Arms (3)

Intervention Group

ACTIVE COMPARATOR

Arm 1 is receiving vitamin D supplementation in 2000 IU/day ,

Drug: Vitamin D supplement

Arm 2 intervention group

ACTIVE COMPARATOR

Arm 2 is receiving vitamin D supplementation in 4000/IU per day

Drug: Vitamin D supplement

Arm 3 control group

ACTIVE COMPARATOR

Arm 3 is receiving vitamin D supplementation in 400 IU/day

Drug: Vitamin D supplement

Interventions

comparison of different dosages of vitamin D

Also known as: Brand name: Vitamin D3, LOT ID AKUH COMPOUNDING 2305012014
Arm 2 intervention groupArm 3 control groupIntervention Group

Eligibility Criteria

Age15 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Pregnant women aged 15 - 45 years
  • Less than 16 weeks pregnant from Last menstrual period.
  • Agree to take part in this study, will be enrolled.

You may not qualify if:

  • Pregnant women with pre existing type 1 or type II diabetes,
  • Pregnant women with pre existing hypertension
  • Women with multiple fetuses, babies (twins, triplets)
  • Women with fetal anomaly in scan
  • Refuse to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aga Khan University

Karachi, Sindh, 75300, Pakistan

Location

Related Publications (6)

  • Farrant HJ, Krishnaveni GV, Hill JC, Boucher BJ, Fisher DJ, Noonan K, Osmond C, Veena SR, Fall CH. Vitamin D insufficiency is common in Indian mothers but is not associated with gestational diabetes or variation in newborn size. Eur J Clin Nutr. 2009 May;63(5):646-52. doi: 10.1038/ejcn.2008.14. Epub 2008 Feb 20.

  • Bodnar LM, Catov JM, Roberts JM, Simhan HN. Prepregnancy obesity predicts poor vitamin D status in mothers and their neonates. J Nutr. 2007 Nov;137(11):2437-42. doi: 10.1093/jn/137.11.2437.

  • Javaid MK, Crozier SR, Harvey NC, Gale CR, Dennison EM, Boucher BJ, Arden NK, Godfrey KM, Cooper C; Princess Anne Hospital Study Group. Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet. 2006 Jan 7;367(9504):36-43. doi: 10.1016/S0140-6736(06)67922-1.

  • Gale CR, Robinson SM, Harvey NC, Javaid MK, Jiang B, Martyn CN, Godfrey KM, Cooper C; Princess Anne Hospital Study Group. Maternal vitamin D status during pregnancy and child outcomes. Eur J Clin Nutr. 2008 Jan;62(1):68-77. doi: 10.1038/sj.ejcn.1602680. Epub 2007 Feb 21.

  • Palacios C, Kostiuk LL, Cuthbert A, Weeks J. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2024 Jul 30;7(7):CD008873. doi: 10.1002/14651858.CD008873.pub5.

  • Nausheen S, Habib A, Bhura M, Rizvi A, Shaheen F, Begum K, Iqbal J, Ariff S, Shaikh L, Raza SS, Soofi SB. Impact evaluation of the efficacy of different doses of vitamin D supplementation during pregnancy on pregnancy and birth outcomes: a randomised, controlled, dose comparison trial in Pakistan. BMJ Nutr Prev Health. 2021 Sep 27;4(2):425-434. doi: 10.1136/bmjnph-2021-000304. eCollection 2021.

Study Officials

  • Sidrah Nausheen, FCPS

    Aga Khan University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 6, 2014

First Posted

August 13, 2014

Study Start

June 1, 2013

Primary Completion

July 1, 2015

Study Completion

January 1, 2016

Last Updated

July 18, 2016

Record last verified: 2016-07

Locations